Table 1.
Demographic and Clinical Characteristics of the Patients at Baseline
Placebo (n = 15) | PBMT-sMF (n = 15) | P value | |
---|---|---|---|
Age (years) | 67.93 (11.68) | 64.2 (18.67) | 0.51 |
Gender (%) | |||
Female | 8 | 6 | |
Male | 6 | 8 | |
Body mass (Kg) | 77.96 (18.49) | 72.40 (16.94) | 0.39 |
Height (cm) | 165.06 (11.57) | 168 (7.98) | 0.42 |
SPAS 3 | 63.40 (13.43) | 59.73 (13.24) | 0.46 |
Comorbidities (%) | |||
Hypertension | 9 (60.0) | 5 (33.3) | |
Diabetes | 8 (53.3) | 4 (26.7) | |
Obesity | 4 (26.7) | 3 (20.0) | |
Dementia | 3 (20.0) | 2 (13.3) | |
Depression | 2 (13.3) | 0 (0.00) |
Notes: Categorical variables are expressed as number (%). Continuous variables are expressed as mean (SD).
Abbreviations: PBMT-sMF, photobiomodulation therapy combined with static magnetic field; SAPS 3, Simplified Acute Physiology Score 3.